C Rad Stock

C Rad EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of C Rad (CRAD B.ST) as of Aug 12, 2026 is 20.78. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 13.28 — a change of 56.43% (higher).

EV/EBIT

20.78

YoY

56.43%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of C Rad is 2026 20.78 . EV/EBIT (Enterprise Value to EBIT) of C Rad was 2025 13.28 . It decreases by 56.43% higher compared to the previous year.

The C Rad EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
442.27 base
Jan 1, 2020
79.88 base
Jan 1, 2021
51.69 base
Jan 1, 2022
59.12 base
Jan 1, 2023
28.47 base
Jan 1, 2024
14.36 base
Jan 1, 2025
23.68 base
Jan 1, 2026 (e)
11.53 base
YEARPRICE-TO-EBIT
2026 est 11.53
2025 23.68
2024 14.36
2023 28.47
2022 59.12
2021 51.69
2020 79.88
2019 442.27
2018 -
2017 -83.83
2016 -10.20
2015 -15.79
Access this data via the Eulerpool API

C Rad Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides C Rad's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates C Rad's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots C Rad's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if C Rad grows earnings faster than its peers.

C Rad Stock analysis

What does C Rad do? The company C Rad AB is a Swedish company based in Uppsala, founded in 1989. The company specializes in the development and production of products for medical imaging, particularly for radiology. Since its founding, the company has become a global provider of innovative solutions for radiology and nuclear medicine. The main goal of C Rad AB is to improve patient care and workflow in radiology by offering solutions that increase treatment efficiency and quality. C Rad's products are tailored to the needs of radiologists, technicians, and patients, aiming to make operation simple and intuitive. The company offers a wide range of products divided into various categories. One of the main categories is computed tomography (CT), for which C Rad has developed a range of accessories. These accessories aim to improve the image quality of CT scans and reduce the dose of ionizing radiation for patients and medical personnel. An example of such an accessory is a special software for analyzing lung images, which works in real time and enables radiologists to make quick and accurate diagnoses. Another important category for C Rad is magnetic resonance imaging (MRI). Here, the company offers a range of products that adapt to the needs of radiologists and patients. One such solution is magnetic muscle stimulation. This technology uses strong magnetic fields to stimulate patients' muscles, thereby positioning the body for better imaging. This type of solution is particularly useful for patients with limited mobility or individuals who have difficulty remaining still due to pain or discomfort. C Rad also develops products for radiation therapy. Here, the focus is on solutions that help control and reduce radiation dose for patients and medical personnel. Examples include dosimeters that measure radiation dose and allow technicians to accurately determine the radiation dose for each patient. In addition to accessories for medical imaging, C Rad also offers a wide range of software solutions. One such solution is Radimetrics software. This software uses machine learning technologies and provides real-time guidance to doctors and technicians on how to optimize workflow and reduce radiation dose for patients. Another example of C Rad's software solutions is dosimetry software. This solution allows technicians to monitor and control radiation dose and image quality in real time. Such software is particularly useful for monitoring radiation dose in radiation therapy and medical imaging. In conclusion, C Rad AB is a company characterized by innovation and quality. Through the continuous development of new solutions, they aim to improve the lives of patients and medical personnel and increase the efficiency and quality of radiology. C Rad is one of the most popular companies on Eulerpool.

Frequently Asked Questions about C Rad stock

EV/EBIT (Enterprise Value to EBIT) of C Rad is 20.78 in 2026.

EV/EBIT (Enterprise Value to EBIT) of C Rad changed from 13.28 to 20.78, representing a 56.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) C Rad since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s C Rad with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — C Rad

All Key Metrics — C Rad